Adherence and satisfaction with oral hypoglycemic medications: A pilot study in Palestine

International Journal of Clinical Pharmacy

Volumn 33, Issue 6, 2011, Pages 942-948

  Jamous, Raniah M ^a   Sweileh, Waleed M ^b   Abu Taha, Adham S ^b   Sawalha, Ansam F ^b   Zyoud, Sa'Ed H ^c   Morisky, Donald E ^d  

^a Palestinian Military Medical Services   (Palestine)

^b AN NAJAH NATIONAL UNIVERSITY   (Palestine)

^c SCHOOL OF PHYSICS   (Malaysia)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adherence; Diabetes mellitus; Palestine; Satisfaction

Indexed keywords

GLIMEPIRIDE; METFORMIN;

ADULT; AGE; AGED; ARTICLE; CLINICAL ASSESSMENT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DIABETES MELLITUS; DISEASE DURATION; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PALESTINE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PILOT STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE;

ADMINISTRATION, ORAL; ADULT; AGED; ARABS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; ISRAEL; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT SATISFACTION; PILOT PROJECTS; QUESTIONNAIRES; TIME FACTORS;

EID: 83255187241     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-011-9561-7     Document Type: Article

References (31)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53. (Pubitemid 38579764)
2. Wens J, Vermeire E, Royen PV, Sabbe B, Denekens J. GPs' perspectives of type 2 diabetes patients' adherence to treatment: a qualitative analysis of barriers and solutions. BMC Fam Pract. 2005;6(1):20.
3. Breitscheidel L, Stamenitis S, Dippel FW, Schöffski O. Economic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: a review paper. J Med Econ. 2010;13(1):8-15.
4. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836-41. (Pubitemid 44455165)
5. Khattab MS, Aboifotouh MA, Khan MY, Humaidi MA, Al-Kaldi YM. Compliance and control of diabetes in a family practice setting, Saudi Arabia. East Mediterr Health J. 1999;5(4):755-65.
6. Sweileh W, Aker O, Hamooz S. Rate of compliance among patients with diabetes mellitus and hypertension. An-Najah Univ J Res (N Sci). 2005;19:1-11.
7. Shokair FN. Pattern and determinants of compliance of diabetics to health care in Alexandria. A community based study. Bull Alex Fac Med. 2010;34(1):200-10.
8. Shams M, Barakat E. Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt. Saudi Pharm J. 2010; 18(4):225-32.
9. Trinacty CM, Adams AS, Soumerai SB, Zhang F, Meigs JB, Piette JD, Ross-Degnan D. Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res. 2009;9:24.
10. Biderman A, Noff E, Harris SB, Friedman N, Levy A. Treatment satisfaction of diabetic patients: what are the contributing factors? Fam Pract. 2009;26(2):102-8. Epub 2009 Mar
11. Nozaki T, Morita C, Matsubayashi S, Ishido K, Yokoyama H, Kawai K, Matsumoto M, Takii M, Kubo C. Relation between psychosocial variables and the glycemic control of patients with type 2 diabetes: a cross-sectional and prospective study. Biopsychosoc Med. 2009;3(1):4.
12. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97. (Pubitemid 41127293)
13. George CF, Peveler RC, Heiliger S, Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol. 2000;50:166-71. (Pubitemid 30612035)
14. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348-54.
15. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74. (Pubitemid 16125389)
16. Bharmal M, Payne K, Atkinson MJ, Desrosiers MP, Morisky DE, Gemmen E. Validation of an abbreviated treatment satisfaction questionnaire for medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes. 2009;7:36.
17. Atkinson MJ, Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health. 2005;8(Suppl 1):S9-24.
18. Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004;2:12.
19. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218-24. (Pubitemid 38579798)
20. Melikian C, White TJ, Vanderplas A, Dezii CM, Chang E. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Ther. 2002;24(3):460-7. (Pubitemid 34275867)
21. Adisa R, Alutundu MB, Fakeye TO. Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in southwestern Nigeria. Pharm Pract (Internet). 2009;7(3):163-9.
22. Morello CM, Chynoweth M, Kim H, Singh RF, Hirsch JD. Strategies to improve medication adherence reported by diabetes patients and caregivers: results of a taking control of your diabetes survey (February). Ann Pharmacother. 2011;45(2):145-53.
23. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002;25(3):458-63. (Pubitemid 41103336)
24. Hasio LD, Salmon JW. Predicting adherence to prescription medication purchase among HMO enrollees with diabetes. J Manag Care Pharm. 1999;5(4):336-41.
25. Nicolucci A, Cucinotta D, Squatrito S, Lapolla A, Musacchio N, Leotta S, Vitali L, Bulotta A, Nicoziani P, Coronel G, QuoLITy Study Group. Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2009;19(1):45-53.
26. Pollack MF, Purayidathil FW, Bolge SC, Williams SA. Patientreported tolerability issues with oral antidiabetic agents: associations with adherence; treatment satisfaction and health-related quality of life. Diabetes Res Clin Pract. 2010;87(2):204-10.
27. Bolen S, Feldman L, Vassy J, Wilson L, Yeh H-C, Marinopoulos S, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med. 2007;147(6):386-99. (Pubitemid 351664540)
28. Asche CV, McAdam-Marx C, Shane-McWhorter L, Sheng X, Plauschinat CV. Association between oral antidiabetic use, adverse events and outcomes in patients with type 2 diabetes. Diab Obes Metab. 2008;10(8):638-45. (Pubitemid 352044293)
29. Cramer J. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27:1218-24. (Pubitemid 38579798)
30. Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26:1408-12. (Pubitemid 36929171)
31. Brownlee-Duffeck M, Peterson L, Simonds JF, Goldstein D, Kilo C, Hoette S. The role of health beliefs in the regimen adherence and metabolic control of adolescents and adults with diabetes mellitus. J Consult Clin Psychol. 1987;55:139-44.